Skip to content

Enterprise value at other companies

AngioDynamics logo
AngioDynamicsANGO
$441.62M+30.5%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$4.43B-33.3%
Solventum logo
SolventumSOLV
$16.56B-19.4%
MiMedx Group logo
MiMedx GroupMDXG
$444.66M-56.9%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$588.13M+55.1%
Savara logo
SavaraSVRA
$1.11B+127%

Other financials

Income statement

See full
Revenue$75.3M+22.8%
Gross profit$57.6M+27.1%
Operating income-$1.5M+66.2%
Net income-$1.8M+40.7%
EPS (diluted)-$0.08+38.5%

Balance sheet

See full
Cash & equivalents$75.0M-10.3%
Total debt$15.2M-62.7%
Total equity$217.9M+5.9%
Total assets$272.1M-2.9%

Cash flow

See full
Operating cash flow-$339.0K-181%
CapEx$821.0K+117%
Free cash flow-$1.2M-3,153%

Valuation

See full
Market cap$631.58M+172%
P/E31.1×+16.8×
P/S1.8×+1.0×

Profitability

See full
Gross margin76.4%+1.8pp
Operating margin9.4%+2.4pp
Net margin5.9%+0.4pp
FCF margin11.4%-1.5pp

Returns & leverage

See full
Return on equity9.6%+1.5pp
Debt / equity0.1×-0.1×
Current ratio4.2×-0.3×

Where this comes from

Calculated from Tactile Systems Technology’s reported figures.

The official record: Tactile Systems Technology’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tactile Systems Technology's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tactile Systems Technology's enterprise value?
Tactile Systems Technology (TCMD) reported enterprise value of $534.65M in Q1 2026.
How has Tactile Systems Technology's enterprise value changed year-over-year?
Tactile Systems Technology's enterprise value increased by 98.1% year-over-year, from $269.93M to $534.65M.
What is the long-term trend for Tactile Systems Technology's enterprise value?
Over 5 years (2020 to 2025), Tactile Systems Technology's enterprise value has grown at a -7.7% compound annual growth rate (CAGR), from $864.39M to $580.24M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.